Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age-related Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)WithdrawnNCT01666236
What this trial is testing

Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy

Who this might be right for
Choroidal NeovascularizationRetinal Pigment Epithelial Detachment
Federal University of São Paulo
Post-approval studies (Phase 4)Ended earlyNCT04563299
What this trial is testing

Effect on Pain and Inflammation With DEXTENZA Treatment in Patients Undergoing Intravitreal Anti-VEGF Injections

Who this might be right for
Neovascular Age-related Macular DegenerationDiabetic Macular EdemaRetinal Vein Occlusion
Retina Vitreous Associates of Florida 10
Not applicableStudy completedNCT01316198
What this trial is testing

Effects of Xanthophylls on Optical Density

Who this might be right for
Age-Related Macular Degeneration
University of Jena 20
Not applicableStudy completedNCT02051140
What this trial is testing

The Effect of Dietary Strawberry Supplementation on Older Adults

Who this might be right for
AgingAge-related Memory Disorders
USDA Human Nutrition Research Center on Aging 54
Not applicableLooking for participantsNCT06718010
What this trial is testing

The Association Between Age-related Peripheral Blood Components and Treatment Efficacy in Breast Cancer

Who this might be right for
Breast CancerAge
Fudan University 120
Early research (Phase 1)Study completedNCT06006585
What this trial is testing

Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Who this might be right for
Geographic Atrophy
Boehringer Ingelheim 20
Testing effectiveness (Phase 2)Study completedNCT02684578
What this trial is testing

Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD

Who this might be right for
Age-Related Macular DegenerationMacular Degeneration, Age-RelatedDry Macular Degeneration+1 more
University of California, San Francisco 66
Not applicableUnknownNCT02119078
What this trial is testing

Acute Care for Elders (ACE) Program at OHSU Hospital

Who this might be right for
DeliriumAge-Related Cognitive DeclineFrail Elderly+2 more
Oregon Health and Science University 300
Testing effectiveness (Phase 2)Study completedNCT00000390
What this trial is testing

Antidepressant Treatment of AIDS Related Depression.

Who this might be right for
Depression
GEIGY Pharmaceuticals
Not applicableStudy completedNCT04770259
What this trial is testing

Pre-surgical Protocol for Frail Elderly People in Order to Reduce Hospitalization Days (APOPM).

Who this might be right for
SurgeryOld Age; DebilityFrail Elderly Syndrome+7 more
Pontificia Universidad Catolica de Chile 87
Post-approval studies (Phase 4)Looking for participantsNCT05093374
What this trial is testing

Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting

Who this might be right for
Exudative Macular Degeneration
Medical University of Vienna 290
Not applicableStudy completedNCT04776031
What this trial is testing

Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes

Who this might be right for
Early Age Related Macular Degeneration (Disorder)
Lutronic Vision, Inc 31
Post-approval studies (Phase 4)Ended earlyNCT02002377
What this trial is testing

Intravitreal Aflibercept in Wet Age Related Macular Degeneration Patients With an Incomplete Response to Routine Ranibizumab Injections

Who this might be right for
Age Related Macular Degeneration
Unity Health Toronto 23
Not applicableStudy completedNCT04187157
What this trial is testing

Association Between Light Spectrum and Survival After Cataract Surgery

Who this might be right for
CataractAge-related CataractCircadian Rhythm Disorders+2 more
University of Pittsburgh 10,192
Not applicableUnknownNCT02220322
What this trial is testing

Age-related Cognitive Change of Femur

Who this might be right for
Osteoporosis
Tomidahama Hospital 1,000
Not applicableUnknownNCT04929756
What this trial is testing

Eye Movement Rehabilitation in Low Vision Patients

Who this might be right for
Low VisionAge Related Macular Degeneration
Northeastern University 106
Not applicableWithdrawnNCT04757831
What this trial is testing

Coronavirus-19 (COVID-19) and Related Outcomes in School Aged Children (ABC Health Outcomes in Children)

Who this might be right for
Covid19; MIS-C
Duke University
Testing effectiveness (Phase 2)Study completedNCT01242254
What this trial is testing

A Study Assessing the Safety and Efficacy of Multiple Intravitreal KH902 in Patients With CNV Due to AMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Chengdu Kanghong Biotech Co., Ltd. 36
Testing effectiveness (Phase 2)Looking for participantsNCT07029945
What this trial is testing

The Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Who this might be right for
Geographic Atrophy
Biojiva LLC 152
Testing effectiveness (Phase 2)Study completedNCT00775411
What this trial is testing

Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD)

Who this might be right for
Choroidal NeovascularizationAge-Related Maculopathy
Allergan 44
Next Page